These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9418191)

  • 1. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis.
    Smith GM; Biggs J; Norris B; Anderson-Stewart P; Ward R
    J Clin Immunol; 1997 Nov; 17(6):502-9. PubMed ID: 9418191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical antitumor activity of an antibody against the leukocyte antigen CD48.
    Sun H; Norris BJ; Atkinson K; Biggs JC; Smith GM
    Clin Cancer Res; 1998 Apr; 4(4):895-900. PubMed ID: 9563883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human leucocyte antigen CD48 (MEM-102) is closely related to the activation marker Blast-1.
    Korínek V; Stefanová I; Angelisová P; Hilgert I; Horejsí V
    Immunogenetics; 1991; 33(2):108-12. PubMed ID: 1999350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both human alpha/beta and gamma interferons upregulate the expression of CD48 cell surface molecules.
    Tissot C; Rebouissou C; Klein B; Mechti N
    J Interferon Cytokine Res; 1997 Jan; 17(1):17-26. PubMed ID: 9041467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.
    Pui CH; Ip SH; Dodge RK; Carrabis S; Brown M; Crist WM; Berard CW; Kung P; Dahl GV; Murphy SB
    Blood; 1988 Sep; 72(3):1015-21. PubMed ID: 2970871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Blast-1 activation/adhesion molecule and its identification as CD48.
    Yokoyama S; Staunton D; Fisher R; Amiot M; Fortin JJ; Thorley-Lawson DA
    J Immunol; 1991 Apr; 146(7):2192-200. PubMed ID: 1848579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel non-lineage antigen on human leucocytes: characterization with two CD-48 monoclonal antibodies.
    Henniker AJ; Bradstock KF; Grimsley P; Atkinson MK
    Dis Markers; 1990; 8(4):179-90. PubMed ID: 2088634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
    Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
    J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive assay for detecting low-affinity interactions at the cell surface reveals no additional ligands for the adhesion pair rat CD2 and CD48.
    Brown MH; Preston S; Barclay AN
    Eur J Immunol; 1995 Dec; 25(12):3222-8. PubMed ID: 8566004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of membrane and soluble interleukin-6 receptor in lymphoid malignancies.
    Lavabre-Bertrand T; Exbrayat C; Liautard J; Gaillard JP; Baskevitch PP; Poujol N; Duperray C; Bourquard P; Brochier J
    Br J Haematol; 1995 Dec; 91(4):871-7. PubMed ID: 8547132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo.
    Chavin KD; Qin L; Lin J; Woodward J; Baliga P; Kato K; Yagita H; Bromberg JS
    Int Immunol; 1994 May; 6(5):701-9. PubMed ID: 7521667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat.
    Miura D; Dobrovolsky VN; Kasahara Y; Katsuura Y; Heflich RH
    Environ Mol Mutagen; 2008 Oct; 49(8):614-21. PubMed ID: 18626999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD48 expression on leukocytes in infectious diseases: flow cytometric analysis of surface antigen.
    Katsuura M; Shimizu Y; Akiba K; Kanazawa C; Mitsui T; Sendo D; Kawakami T; Hayasaka K; Yokoyama S
    Acta Paediatr Jpn; 1998 Dec; 40(6):580-5. PubMed ID: 9893294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis.
    Abadía-Molina AC; Ji H; Faubion WA; Julien A; Latchman Y; Yagita H; Sharpe A; Bhan AK; Terhorst C
    Gastroenterology; 2006 Feb; 130(2):424-34. PubMed ID: 16472597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ligand for human CD48 on epithelial cells.
    Ianelli CJ; Edson CM; Thorley-Lawson DA
    J Immunol; 1997 Oct; 159(8):3910-20. PubMed ID: 9378979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
    Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
    J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation.
    González-Cabrero J; Wise CJ; Latchman Y; Freeman GJ; Sharpe AH; Reiser H
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):1019-23. PubMed ID: 9927686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homotypic adhesion of rat B cells, but not T cells, in response to cross-linking of CD48.
    Garnett D; Williams AF
    Immunology; 1994 Jan; 81(1):103-10. PubMed ID: 8132206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD48 as a novel molecular target for antibody therapy in multiple myeloma.
    Hosen N; Ichihara H; Mugitani A; Aoyama Y; Fukuda Y; Kishida S; Matsuoka Y; Nakajima H; Kawakami M; Yamagami T; Fuji S; Tamaki H; Nakao T; Nishida S; Tsuboi A; Iida S; Hino M; Oka Y; Oji Y; Sugiyama H
    Br J Haematol; 2012 Jan; 156(2):213-24. PubMed ID: 22098460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.